nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2C19—Prednisone—ankylosing spondylitis	0.107	0.117	CbGbCtD
Carbinoxamine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.106	0.116	CbGbCtD
Carbinoxamine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.105	0.115	CbGbCtD
Carbinoxamine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0851	0.0932	CbGbCtD
Carbinoxamine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0794	0.0869	CbGbCtD
Carbinoxamine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0666	0.0729	CbGbCtD
Carbinoxamine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0645	0.0706	CbGbCtD
Carbinoxamine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0554	0.0606	CbGbCtD
Carbinoxamine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0554	0.0606	CbGbCtD
Carbinoxamine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0546	0.0598	CbGbCtD
Carbinoxamine—CYP3A4—Prednisone—ankylosing spondylitis	0.0516	0.0565	CbGbCtD
Carbinoxamine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0506	0.0554	CbGbCtD
Carbinoxamine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0322	0.0353	CbGbCtD
Carbinoxamine—Neuritis—Prednisolone—ankylosing spondylitis	0.00211	0.0244	CcSEcCtD
Carbinoxamine—Neuritis—Triamcinolone—ankylosing spondylitis	0.00194	0.0224	CcSEcCtD
Carbinoxamine—Neuritis—Methylprednisolone—ankylosing spondylitis	0.00194	0.0224	CcSEcCtD
Carbinoxamine—Neuritis—Dexamethasone—ankylosing spondylitis	0.00176	0.0203	CcSEcCtD
Carbinoxamine—Neuritis—Betamethasone—ankylosing spondylitis	0.00176	0.0203	CcSEcCtD
Carbinoxamine—Neuritis—Prednisone—ankylosing spondylitis	0.00154	0.0177	CcSEcCtD
Carbinoxamine—Wheezing—Triamcinolone—ankylosing spondylitis	0.00141	0.0162	CcSEcCtD
Carbinoxamine—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00136	0.0156	CcSEcCtD
Carbinoxamine—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.00125	0.0144	CcSEcCtD
Carbinoxamine—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.00124	0.0143	CcSEcCtD
Carbinoxamine—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00113	0.013	CcSEcCtD
Carbinoxamine—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00113	0.013	CcSEcCtD
Carbinoxamine—Irritability—Methylprednisolone—ankylosing spondylitis	0.001	0.0116	CcSEcCtD
Carbinoxamine—Euphoric mood—Prednisone—ankylosing spondylitis	0.000985	0.0114	CcSEcCtD
Carbinoxamine—Sweating increased—Prednisolone—ankylosing spondylitis	0.000964	0.0111	CcSEcCtD
Carbinoxamine—Irritability—Dexamethasone—ankylosing spondylitis	0.000912	0.0105	CcSEcCtD
Carbinoxamine—Irritability—Betamethasone—ankylosing spondylitis	0.000912	0.0105	CcSEcCtD
Carbinoxamine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.000887	0.0102	CcSEcCtD
Carbinoxamine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.000885	0.0102	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000865	0.00998	CcSEcCtD
Carbinoxamine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.000805	0.00928	CcSEcCtD
Carbinoxamine—Sweating increased—Betamethasone—ankylosing spondylitis	0.000805	0.00928	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000796	0.00917	CcSEcCtD
Carbinoxamine—Irritability—Prednisone—ankylosing spondylitis	0.000794	0.00916	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000794	0.00915	CcSEcCtD
Carbinoxamine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000792	0.00913	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000722	0.00832	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000722	0.00832	CcSEcCtD
Carbinoxamine—Sweating increased—Prednisone—ankylosing spondylitis	0.000701	0.00808	CcSEcCtD
Carbinoxamine—Irritability—Methotrexate—ankylosing spondylitis	0.000664	0.00765	CcSEcCtD
Carbinoxamine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00065	0.00749	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000629	0.00725	CcSEcCtD
Carbinoxamine—Vertigo—Prednisolone—ankylosing spondylitis	0.00062	0.00715	CcSEcCtD
Carbinoxamine—Convulsion—Prednisolone—ankylosing spondylitis	0.000598	0.00689	CcSEcCtD
Carbinoxamine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00057	0.00657	CcSEcCtD
Carbinoxamine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000569	0.00656	CcSEcCtD
Carbinoxamine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00055	0.00634	CcSEcCtD
Carbinoxamine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000549	0.00633	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000549	0.00633	CcSEcCtD
Carbinoxamine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000548	0.00632	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000544	0.00627	CcSEcCtD
Carbinoxamine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000536	0.00618	CcSEcCtD
Carbinoxamine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000521	0.006	CcSEcCtD
Carbinoxamine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000517	0.00596	CcSEcCtD
Carbinoxamine—Vertigo—Betamethasone—ankylosing spondylitis	0.000517	0.00596	CcSEcCtD
Carbinoxamine—Insomnia—Prednisolone—ankylosing spondylitis	0.000509	0.00587	CcSEcCtD
Carbinoxamine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000505	0.00583	CcSEcCtD
Carbinoxamine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000505	0.00583	CcSEcCtD
Carbinoxamine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000504	0.00581	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.0005	0.00577	CcSEcCtD
Carbinoxamine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.0005	0.00577	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000499	0.00576	CcSEcCtD
Carbinoxamine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000499	0.00575	CcSEcCtD
Carbinoxamine—Convulsion—Betamethasone—ankylosing spondylitis	0.000499	0.00575	CcSEcCtD
Carbinoxamine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000483	0.00556	CcSEcCtD
Carbinoxamine—Vision blurred—Prednisone—ankylosing spondylitis	0.000472	0.00545	CcSEcCtD
Carbinoxamine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000468	0.0054	CcSEcCtD
Carbinoxamine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000467	0.00539	CcSEcCtD
Carbinoxamine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000465	0.00536	CcSEcCtD
Carbinoxamine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000464	0.00535	CcSEcCtD
Carbinoxamine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000464	0.00535	CcSEcCtD
Carbinoxamine—Agitation—Prednisone—ankylosing spondylitis	0.000461	0.00531	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00046	0.0053	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00046	0.0053	CcSEcCtD
Carbinoxamine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000458	0.00529	CcSEcCtD
Carbinoxamine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000458	0.00529	CcSEcCtD
Carbinoxamine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000456	0.00525	CcSEcCtD
Carbinoxamine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000455	0.00524	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000454	0.00524	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000454	0.00524	CcSEcCtD
Carbinoxamine—Vertigo—Prednisone—ankylosing spondylitis	0.00045	0.00519	CcSEcCtD
Carbinoxamine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000449	0.00517	CcSEcCtD
Carbinoxamine—Anorexia—Betamethasone—ankylosing spondylitis	0.000448	0.00516	CcSEcCtD
Carbinoxamine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000448	0.00516	CcSEcCtD
Carbinoxamine—Urticaria—Prednisolone—ankylosing spondylitis	0.000447	0.00516	CcSEcCtD
Carbinoxamine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000446	0.00515	CcSEcCtD
Carbinoxamine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000445	0.00513	CcSEcCtD
Carbinoxamine—Hypotension—Betamethasone—ankylosing spondylitis	0.000439	0.00506	CcSEcCtD
Carbinoxamine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000439	0.00506	CcSEcCtD
Carbinoxamine—Convulsion—Prednisone—ankylosing spondylitis	0.000434	0.00501	CcSEcCtD
Carbinoxamine—Chills—Methotrexate—ankylosing spondylitis	0.000432	0.00498	CcSEcCtD
Carbinoxamine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000427	0.00492	CcSEcCtD
Carbinoxamine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000426	0.00491	CcSEcCtD
Carbinoxamine—Insomnia—Betamethasone—ankylosing spondylitis	0.000425	0.0049	CcSEcCtD
Carbinoxamine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000425	0.0049	CcSEcCtD
Carbinoxamine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000422	0.00486	CcSEcCtD
Carbinoxamine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000422	0.00486	CcSEcCtD
Carbinoxamine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000413	0.00477	CcSEcCtD
Carbinoxamine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000413	0.00477	CcSEcCtD
Carbinoxamine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000411	0.00474	CcSEcCtD
Carbinoxamine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00041	0.00473	CcSEcCtD
Carbinoxamine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000408	0.00471	CcSEcCtD
Carbinoxamine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000408	0.00471	CcSEcCtD
Carbinoxamine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000405	0.00467	CcSEcCtD
Carbinoxamine—Fatigue—Betamethasone—ankylosing spondylitis	0.000405	0.00467	CcSEcCtD
Carbinoxamine—Tachycardia—Prednisone—ankylosing spondylitis	0.000399	0.0046	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000395	0.00456	CcSEcCtD
Carbinoxamine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000395	0.00455	CcSEcCtD
Carbinoxamine—Anorexia—Prednisone—ankylosing spondylitis	0.00039	0.0045	CcSEcCtD
Carbinoxamine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000387	0.00446	CcSEcCtD
Carbinoxamine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000387	0.00446	CcSEcCtD
Carbinoxamine—Vertigo—Methotrexate—ankylosing spondylitis	0.000376	0.00434	CcSEcCtD
Carbinoxamine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000373	0.0043	CcSEcCtD
Carbinoxamine—Urticaria—Betamethasone—ankylosing spondylitis	0.000373	0.0043	CcSEcCtD
Carbinoxamine—Dizziness—Prednisolone—ankylosing spondylitis	0.000372	0.00429	CcSEcCtD
Carbinoxamine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000371	0.00428	CcSEcCtD
Carbinoxamine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000371	0.00427	CcSEcCtD
Carbinoxamine—Insomnia—Prednisone—ankylosing spondylitis	0.00037	0.00427	CcSEcCtD
Carbinoxamine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000367	0.00424	CcSEcCtD
Carbinoxamine—Convulsion—Methotrexate—ankylosing spondylitis	0.000363	0.00418	CcSEcCtD
Carbinoxamine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00036	0.00415	CcSEcCtD
Carbinoxamine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000356	0.0041	CcSEcCtD
Carbinoxamine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000353	0.00407	CcSEcCtD
Carbinoxamine—Fatigue—Prednisone—ankylosing spondylitis	0.000353	0.00407	CcSEcCtD
Carbinoxamine—Headache—Prednisolone—ankylosing spondylitis	0.000353	0.00407	CcSEcCtD
Carbinoxamine—Constipation—Prednisone—ankylosing spondylitis	0.00035	0.00403	CcSEcCtD
Carbinoxamine—Confusional state—Methotrexate—ankylosing spondylitis	0.000345	0.00397	CcSEcCtD
Carbinoxamine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000342	0.00395	CcSEcCtD
Carbinoxamine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000342	0.00394	CcSEcCtD
Carbinoxamine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000337	0.00389	CcSEcCtD
Carbinoxamine—Asthenia—Betamethasone—ankylosing spondylitis	0.000337	0.00389	CcSEcCtD
Carbinoxamine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000337	0.00389	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000335	0.00386	CcSEcCtD
Carbinoxamine—Nausea—Prednisolone—ankylosing spondylitis	0.000334	0.00386	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00033	0.00381	CcSEcCtD
Carbinoxamine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000329	0.0038	CcSEcCtD
Carbinoxamine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000328	0.00379	CcSEcCtD
Carbinoxamine—Anorexia—Methotrexate—ankylosing spondylitis	0.000326	0.00376	CcSEcCtD
Carbinoxamine—Urticaria—Prednisone—ankylosing spondylitis	0.000325	0.00375	CcSEcCtD
Carbinoxamine—Headache—Triamcinolone—ankylosing spondylitis	0.000324	0.00374	CcSEcCtD
Carbinoxamine—Headache—Methylprednisolone—ankylosing spondylitis	0.000324	0.00373	CcSEcCtD
Carbinoxamine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000321	0.00371	CcSEcCtD
Carbinoxamine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000321	0.00371	CcSEcCtD
Carbinoxamine—Hypotension—Methotrexate—ankylosing spondylitis	0.000319	0.00368	CcSEcCtD
Carbinoxamine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000311	0.00358	CcSEcCtD
Carbinoxamine—Dizziness—Betamethasone—ankylosing spondylitis	0.000311	0.00358	CcSEcCtD
Carbinoxamine—Insomnia—Methotrexate—ankylosing spondylitis	0.000309	0.00357	CcSEcCtD
Carbinoxamine—Nausea—Triamcinolone—ankylosing spondylitis	0.000307	0.00355	CcSEcCtD
Carbinoxamine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000307	0.00354	CcSEcCtD
Carbinoxamine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000307	0.00354	CcSEcCtD
Carbinoxamine—Somnolence—Methotrexate—ankylosing spondylitis	0.000304	0.0035	CcSEcCtD
Carbinoxamine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000301	0.00347	CcSEcCtD
Carbinoxamine—Vomiting—Betamethasone—ankylosing spondylitis	0.000299	0.00344	CcSEcCtD
Carbinoxamine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000299	0.00344	CcSEcCtD
Carbinoxamine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000297	0.00343	CcSEcCtD
Carbinoxamine—Fatigue—Methotrexate—ankylosing spondylitis	0.000295	0.0034	CcSEcCtD
Carbinoxamine—Headache—Dexamethasone—ankylosing spondylitis	0.000294	0.00339	CcSEcCtD
Carbinoxamine—Headache—Betamethasone—ankylosing spondylitis	0.000294	0.00339	CcSEcCtD
Carbinoxamine—Asthenia—Prednisone—ankylosing spondylitis	0.000293	0.00338	CcSEcCtD
Carbinoxamine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000282	0.00325	CcSEcCtD
Carbinoxamine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00028	0.00323	CcSEcCtD
Carbinoxamine—Nausea—Betamethasone—ankylosing spondylitis	0.000279	0.00322	CcSEcCtD
Carbinoxamine—Nausea—Dexamethasone—ankylosing spondylitis	0.000279	0.00322	CcSEcCtD
Carbinoxamine—Urticaria—Methotrexate—ankylosing spondylitis	0.000272	0.00313	CcSEcCtD
Carbinoxamine—Dizziness—Prednisone—ankylosing spondylitis	0.000271	0.00312	CcSEcCtD
Carbinoxamine—Vomiting—Prednisone—ankylosing spondylitis	0.00026	0.003	CcSEcCtD
Carbinoxamine—Headache—Prednisone—ankylosing spondylitis	0.000256	0.00295	CcSEcCtD
Carbinoxamine—Asthenia—Methotrexate—ankylosing spondylitis	0.000245	0.00283	CcSEcCtD
Carbinoxamine—Nausea—Prednisone—ankylosing spondylitis	0.000243	0.0028	CcSEcCtD
Carbinoxamine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000234	0.0027	CcSEcCtD
Carbinoxamine—Dizziness—Methotrexate—ankylosing spondylitis	0.000226	0.00261	CcSEcCtD
Carbinoxamine—Vomiting—Methotrexate—ankylosing spondylitis	0.000217	0.00251	CcSEcCtD
Carbinoxamine—Headache—Methotrexate—ankylosing spondylitis	0.000214	0.00247	CcSEcCtD
Carbinoxamine—Nausea—Methotrexate—ankylosing spondylitis	0.000203	0.00234	CcSEcCtD
